SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001136261-17-000293
Filing Date
2017-11-22
Accepted
2017-11-22 08:23:29
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 s3body.htm S-3 276743
2 OPINION exh5-1.htm EX-5.1 15376
3 OPINION exh5-2.htm EX-5.2 6162
4 CONSENT exh23-1.htm EX-23.1 1008
5 LOGO image3262.jpg GRAPHIC 6427
6 LOGO image3263.jpg GRAPHIC 11533
7 LOGO image3264.jpg GRAPHIC 3566
8 LOGO hoganlovells.jpg GRAPHIC 28105
  Complete submission text file 0001136261-17-000293.txt   369137
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221717 | Film No.: 171218405
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1